Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter and full-year financial results for 2025, along with data on their spine orthopedic sales.
Here is how they compare:
2025 sales: $25.1 billion (+11.2%)
2025 Orthopedics: $9.5 billion (+4.3%)
2025 Hips: $1.9 billion (+9.5%)
2025 Knees: $2.7 billion (+8.5%)
2025 Spine: $185 million
Q4 sales: $7.2 billion (+11.4%)
2025 sales: $8.2 billion (+7.2%)
2025 Hips: $2 million (+4.7%)
2025 Knees: $3.2 billion (+4.7%)
2025 Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $2.1 billion (+15.2%)
Q4 sales: $2.24 billion
2025 Medtech sales: $94.2 billion (+6%)
2025 Orthopedic: $9.2 billion (+1.1%)
2025 Spine, sports and other: $2.8 billion (-2.5%)
2025 Hips: $1.67 billion (+2.1%)
2025 Knees: $1.58 billion (+2.7%)
Q4 sales: $24.6 billion (+9.1%)
